Did You Know...
...that two musicians were responsible for the invention of color print film? Fascinated by photography, Leopold Godowsky and Leopold Mannes worked together to produce an easy-to-use, practical color film. They worked full time as music teachers and gave concerts while experimenting during their off hours in Mannes' kitchen. Their success earned them full-time, well-paying jobs at Kodak and their efforts resulted in Kodachrome film, which was introduced in 1935.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7759334 | Soluble forms of amoxicillin and treatment of animals A solid mixture or aqueous solution of amoxicillin antibacterial agent with a material that aids in its dissolution in water to render it ingestive and palatable. ... | 07/20/2010 |
| 7365047 | Use of pentagastrin to inhibit gastric acid secretion or as a diuretic This invention pertains to the discovery that pentagastrin, when administered in conjunction with a proton pump inhibitor (PPI) is synergistic with the PPI and significantly increases the efficacy of the PPI in reducing/mitigating excess gastric acid secretion. ... | 04/29/2008 |
| 7282221 | Antiviral product, use and formulation thereof An antiviral product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antiviral product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosag... | 10/16/2007 |
| 7244720 | Soluble forms of amoxicillin and treatment of animals A solid mixture or aqueous solution of amoxicillin antibacterial agent with a material that aids in its dissolution in water to render it ingestive and palatable. ... | 07/17/2007 |
| 7091229 | Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors A compound of formula (I) wherein A and B are optionally substituted cyclohexenyl or phenyl groups, X is carbonyl or sulfonyl, and Y is 5–7 atoms-linker, is useful as histone deacetylase inhibitors, particularl... | 08/15/2006 |
| 6946477 | 3-Substituted piperidines comprising urea functionality, and methods of use thereof One aspect of the present invention relates to novel heterocyclic compounds comprising urea functionality. A second aspect of the present invention relates to the use of the novel heterocyclic compounds comprising urea functionality as ligands for various cellular r... | 09/20/2005 |
| 6833389 | Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful for the treatment Chlamydia pneumoniae infections is described. ... | 12/21/2004 |
| 6756369 | Diagnosis and management of infection caused by Chlamydia The present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly C. pneumoniae. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stag... | 06/29/2004 |
| 6743440 | Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals A composition, preferably used to reduce methane formation in a ruminant, wherein the composition is a combination of a polycyclic quinone compound and an ionophore compound. ... | 06/01/2004 |
| 6664239 | Diagnosis and management of infection caused by Chlamydia The present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly C. pneumoniae. The invention is based, in part, upon the discovery that a combination of agents directed toward the various ... | 12/16/2003 |
| 6627625 | Treatment of behavioral disorders with ଲ-lactam compounds Administration of ଲ-lactam compounds including ଲ-lactam antibiotics and ଲ-lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and anti-aggressive behavior modificat... | 09/30/2003 |
| 6599892 | 7-alkylidene cephalosporanic acid derivatives and methods of using the same Derivatives of 7-alkylidene cephalosporanic acid sulfone and the pharmaceutically active salts thereof are found to be potent inhibitors of ଲ-lactamase enzymes.... | 07/29/2003 |
| 6537985 | Antibiotic formulation and a method of making this formulation An antibiotic formulation in a true solution is provided. This formulation includes an antibiotic and N-methyl-2-pyrrolidone. It also may include a preservative, an antioxidant, and/or an additive. The antibiotic is a beta lactam, such as a penicillin, a ... | 03/25/2003 |
| 6492354 | Soluble forms of amoxicillin and treatment of animals A solid mixture or aqueous solution of amoxicillin antibacterial agent with a material that aids in its dissolution in water to render it ingestive and palatable.... | 12/10/2002 |
| 6461607 | Probiotic, lactic acid-producing bacteria and uses thereof The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-pro... | 10/08/2002 |
| 6429191 | Treatment of hearing impairments Compositions and methods are provided for prophylactic or therapeutic treatment of a mammal for hearing impairments involving neuronal damage, loss, or degeneration, preferably of spinal ganglion neurons, by administration of a therapeutically effective a... | 08/06/2002 |
| 6417174 | Inhibitors of ଲ-lactamases and uses therefor The invention provides novel non-ଲ-lactam inhibitors of ଲ-lactamases. In particular, the invention provides such inhibitors which are boronic acids of formula (1) which is set forth in the specification. These compounds may be used with ³... | 07/09/2002 |
| 6316015 | Hyperbactericidal surfaces A surface is provided with antibiotic or antiseptic properties. A solid substrate is modified by covalently fixing one or more spacers having reactive extremities via a proximate reactive extremity, and one or more antibiotic, bactericidal, viricidal or f... | 11/13/2001 |
| 6303644 | Proton pump inhibitor in therapeutic combination with antibacterial substances The invention relates to the use of proton pump inhibitors as combination therapeutics in the treatment of bacterial diseases which do not affect the gastrointestinal track using antibacterially active compounds.... | 10/16/2001 |
| 6225282 | Treatment of hearing impairments Compositions and methods are provided for prophylactic or therapeutic treatment of a mammal for hearing impairments involving neuronal damage, loss, or degeneration, preferably of spinal ganglion neurons, by administration of a therapeutically effective a... | 05/01/2001 |
| 6225304 | Soluble forms of amoxicillin and treatment of animals A solid mixture or aqueous solution of amoxicillin antibacterial agent with a material that aids in its dissolution in water to render it ingestive and palatable.... | 05/01/2001 |
| 6221859 | Carbapenem antibacterial compositions and methods of the treatment The present invention relates to novel 2-(naphthosultamyl)methyl-carbapenem antibacterial agents or pharmaceutically acceptable salts thereof in combination with other ଲ-lactams, which are useful in treating and preventing enterococcal infections. T... | 04/24/2001 |
| 6187768 | Kit for flushing medical devices and method of preparation A kit and for flushing a medical device a method of preparing the kit is disclosed. The kit includes a container containing a mixed solution a unit dose of a pharmacologically effective amount of an antimicrobial agent and a second agent. The mixed soluti... | 02/13/2001 |
| 6159706 | Application of enzyme prodrugs as anti-infective agents The present invention provides a method for targeting toxic antimetabolites to gram negative infections. It provides a means of taking advantage of a key disease resistance mechanism to activate these drugs locally, and to overcome the resistance phenotyp... | 12/12/2000 |
| 6143742 | Treatment for necrotizing infections The treatment of for arresting the destructive effects of proteolytic enzymes produced by a host infecting organism, such as "flesh eating bacteria", is carried out using therapy with includes the administration of one or more protease inhibitors.... | 11/07/2000 |
| 6127355 | High molecular weight polymer-based prodrugs The present invention is directed compositions of the formula: ##STR1## wherein: D is a residue of a biologically active moiety; X is an electron withdrawing group; Y and Y' are independently O or S; (n) is zero (0) or a positive integer, preferably from 1 to ... | 10/03/2000 |
| 6093414 | Silver-based antimicrobial compositions The present invention relates generally to silver-based antimicrobial compositions and processes for making such compositions. More particularly, the present invention describes stable, purified silver-based antimicrobial compositions, and processes for m... | 07/25/2000 |
| 6051604 | Methods and compositions for the prevention and treatment of gastrointestinal disorders The subject invention encompasses methods for prevention and treatment of a human or lower animal subject having a gastrointestinal disorder caused or mediated by one or more intestinal helminths comprising administering to the subject bismuth and one or ... | 04/18/2000 |
| 5972309 | Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment Intra-erythrocytic exogenous bacterial structures or parasites seen by giemsa and phase contrast microscopy in several patients with systemic lupus erythematosus (SLE) and not in controls were identified as bacteria. Treatment of an SLE patient is contemp... | 10/26/1999 |
| 5948422 | Oral dosage-forms containing a ଲ-lactam antibiotic A granulate, containing at least 50 wt. % of a water soluble ଲ-lactam antibiotic, is provided. A process to prepare a granulate containing such ଲ-lactam antibiotic comprises moistening components making up the granulate with an aqueous solutio... | 09/07/1999 |
| 5935603 | Water soluble powder form compositions and their applications thereof Water soluble, powder form compositions suitable for completely and rapidly dissolving active ingredients which usually only dissolve in water in the presence of base salts, such as antibiotics of the betalactamide family, for example penicillins and thei... | 08/10/1999 |
| 5883074 | Potentiators of antibacterial agents Methods for screening for compounds which potentiate the activity of antibacterial agents against bacteria resistant to the antibacterial agent alone, pharmaceutical compositions including such potentiators, and methods of treating bacterial infections us... | 03/16/1999 |
| 5827543 | Methods and compositions for the prevention and treatment of urogenital disorders The subject invention encompasses methods for prevention and treatment of a human or lower animal subject having a urogenital disorder caused or mediated by one or more parasitic protozoa comprising administering to the subject bismuth and one or more ant... | 10/27/1998 |
| 5795563 | Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment Intra-erythrocytic exogenous bacterial structures or parasites seen by giemsa and phase contrast microscopy in several patients with systemic lupus erythematosus (SLE) and not in controls were identified as bacteria. Treatment of an SLE patient is contemp... | 08/18/1998 |
| 5780049 | Enhanced skin penetration system for improved topical delivery of drugs The invention involves pharmaceutical compositions for topical application comprising: (a) a safe and effective amount of a pharmaceutical active; and (b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular wight of from about 1,000,0... | 07/14/1998 |
| 5770585 | Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal This invention is directed to a homogenous water-in-perfluorochemical stable liquid dispersion for acceptable therapeutic administration of a drug to the lung of an animal. The dispersion includes a perfluorochemical liquid, water, surfactant and drug, wh... | 06/23/1998 |
| 5744168 | Methods and compositions for the prevention and treatment of gastrointestinal disorders The subject invention encompasses methods for prevention and treatment of a human or lower animal subject having a gastrointestinal disorder caused or mediated by algae and/or cyanobacteria comprising administering to the subject bismuth and one or more a... | 04/28/1998 |
| 5712268 | Compositions of tricyclic ଲ-lactams and uses thereof There are described pharmaceutical compositions comprising (a) compounds of the formula ##STR1## in which R signifies lower alkoxycarbonyl, lower alkoxy-carbonylamino, the acyl residue of an - or ଲ-amino acid or a residue of the general... | 01/27/1998 |
| 5698577 | Compositions of bicyclic ଲ-lactams and uses thereof There are described pharmaceutical compositions comprising (a) compounds of the formula ##STR1## in which R signifies lower alkoxycarbonyl, lower alkoxy-carbonylamino, the acyl residue of an - or ଲ-amino acid or a residue of the general... | 12/16/1997 |
| 5698533 | Ophthalmic pharmaceutical composition A method of administering a drug to an eye including the steps of: (a) admixing a pharmaceutically acceptable hydrocarbonaceous semi-solid or oil which contains the drug with water at a temperature above the melting point of the semi-solid or oil; and (b)... | 12/16/1997 |
